Orlowski, R., Shah, M., Chakraborty, R., Fernandez-Abellán, P., Leleu, X., Oriol, A., Schade, H., Stevens, D., Garderet, L., Larson, S., Lee, L., Michot, J., Morgan, G., Schuster, M., Breazna, A., Aina, O., Dhadwal, A., Sims, J., Shemesh, C. S., Hazra, A., Lee, D., Kroog, G., Lorenc, K. R., Quatela, S. E., Ferreri, C. (2025). Safety and efficacy of linvoseltamab as a simplified monotherapy first-line regimen in NDMM: Initial Results from the window of opportunity Phase 1/2 LINKER-MM4 trial. Blood. https://doi.org/10.1182/blood-2025-697